Chinese inhibitor drug candidate becomes first to enter phase
Release time：2024-05-21 17:14:24 Source：Worldly Window news portal
Chinese biotech company Jacobio Pharma announced on Monday that it had received approval from Chinese regulatory authorities for the registration phase-3 clinical trial of a combination therapy using its SHP2 inhibitor drug candidate JAB-3312.
SHP2 inhibitors are expected worldwide to have a substantial clinical effect in cancer and immunity disease treatment, and the approval made JAB-3312 the first SHP2 inhibitor to enter the phase-3 clinical study globally.
The approved clinical study in China is designed to evaluate the efficacy and safety of JAB-3312 in combination with the company's other investigational drug candidate KRAS G12C inhibitor glecirasib, for treating first-line non-small cell lung cancer patients with KRAS G12C mutations.
The control arm is the current standard treatment for first-line non-small cell lung cancer, which is the combination therapy of PD-1 antibody and chemotherapy.
- Previous：Pentagon vows to keep weapons moving to Ukraine as Kyiv faces a renewed assault by Russia
- Next：Why US Catholics are planning pilgrimages in communities across the nation
Related articles
- I was 'brokefished' by my friend for £400
- Israeli military renews warnings to Palestinians not to return to war
- Couple Establishes Workshop to Develop Early Childhood Education in Community
- Spring Festival holiday spurs duty
- Iran helicopter crash that killed President Raisi could reverberate across the Middle East
- A Star in Her Own Right — Ye Shuhua Dedicates Life to Development of Nation, Astronomy
- Kyrgyz Woman Finds Love, Career in Xi'an
- La Liga reduces Barcelona's spending cap to €204m
- Amtrak train hits pickup truck in upstate New York, 3 dead including child
- Dancing to a London Beat
- Minnesota Uber and Lyft driver pay package beats deadline to win approval in Legislature
- Village Official Leads Farmers in Promoting Rural Revitalization
- Couple Establishes Workshop to Develop Early Childhood Education in Community
- Peng Yan Leads Team in Developing USVs
- Kosovo prepares a new draft law on renting prison cells to Denmark after the first proposal failed
- Highlights of esports matches at 19th Asian Games
- Providing Heartwarming Services to Children
- Much at stake for Barca, Xavi in Napoli trip
- Amtrak train hits pickup truck in upstate New York, 3 dead including child
- 'Puppet Sister' Creates 'Intelligent' Robot Performers
Random recommendation
- Copyright © 2024 Powered by Chinese inhibitor drug candidate becomes first to enter phase ,Worldly Window news portal sitemap